Modulation of dendritic cell function by the radiation-mediated secretory protein γ-synuclein

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Gamma-synuclein (SNCG), also known as breast cancer-specific gene-1, is an aggressive marker in breast cancer.
• Previous studies showed SNCG upregulation in irradiated human breast cancer cells.

Purpose of the Study:

• To investigate the influence of radiation-induced, tumor-derived SNCG on dendritic cell (DC) function.
• To explore SNCG's role in modulating immune system responses within the tumor microenvironment.

Main Methods:

• Flow cytometry (FACS) analysis for phenotypical changes in DCs.
• Enzyme-linked immunosorbent assay (ELISA) and real-time PCR for functional and molecular analysis.
• Co-culturing SNCG-treated DCs with T cells to assess immune modulation.

Main Results:

• SNCG treatment inhibited DC surface expression of co-stimulatory molecules (CD40, CD86) and decreased pro-inflammatory cytokine mRNA.
• SNCG-treated DCs showed slightly reduced T-cell proliferation but a distinct increase in regulatory T cells.
• Co-culture with SNCG-treated DCs significantly increased TGF-β production by T cells.

Conclusions:

• Tumor-derived SNCG contributes to immunosuppression by inhibiting DC differentiation and activation.
• SNCG plays a critical role in creating an immune-suppressive tumor microenvironment.
• SNCG represents a potential therapeutic target for enhancing anti-tumor immunity.